FAP-specific chimeric antigen receptor (CAR) T cells have also demonstrated effectiveness in eliminating FAP+ CAFs and curbing tumor growth in mouse models of lung, mesothelioma, and pancreatic cancers (69–71). This evidence concerns the gene FAP and mesothelioma.